Lexicon Pharmaceuticals, Inc. (LXRX) DCF Valuation

Lexicon Pharmaceuticals, Inc. (LXRX) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

Lexicon Pharmaceuticals, Inc. (LXRX) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Enhance your investment choices with the (LXRX) DCF Calculator! Review authentic Lexicon Pharmaceuticals financials, adjust growth projections and expenses, and instantly observe how these changes affect the intrinsic value of (LXRX).


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 322.1 24.0 .3 .1 1.2 .8 .5 .3 .2 .1
Revenue Growth, % 0 -92.55 -98.76 -53.36 766.19 -36.17 -36.17 -36.17 -36.17 -36.17
EBITDA 173.7 -41.1 -86.7 -98.7 -163.5 -.5 -.3 -.2 -.1 -.1
EBITDA, % 53.94 -171.27 -29081.88 -71033.81 -13576.74 -69.21 -69.21 -69.21 -69.21 -69.21
Depreciation 3.7 2.9 .3 .4 .6 .4 .3 .2 .1 .1
Depreciation, % 1.13 12.23 97.99 307.19 46.01 51.47 51.47 51.47 51.47 51.47
EBIT 170.1 -44.0 -87.0 -99.2 -164.0 -.5 -.3 -.2 -.1 -.1
EBIT, % 52.81 -183.5 -29179.87 -71341.01 -13622.76 -69.44 -69.44 -69.44 -69.44 -69.44
Total Cash 271.7 152.3 86.7 138.4 170.0 .7 .5 .3 .2 .1
Total Cash, percent .0 .0 .0 .1 .0 .0 .0 .0 .0 .0
Account Receivables 56.5 .4 .0 .0 1.0
Account Receivables, % 17.55 1.65 4.7 20.14 83.89
Inventories 4.2 .0 .0 .0 .4 .1 .0 .0 .0 .0
Inventories, % 1.32 0.000004167535 0 0 31.64 6.59 6.59 6.59 6.59 6.59
Accounts Payable 12.2 5.5 9.2 10.4 14.4 .5 .3 .2 .1 .1
Accounts Payable, % 3.78 22.79 3071.14 7478.42 1195.1 65.31 65.31 65.31 65.31 65.31
Capital Expenditure -.1 -.1 -1.2 -1.3 -.5 -.4 -.2 -.1 -.1 -.1
Capital Expenditure, % -0.0217342 -0.36258 -409.73 -953.96 -39.04 -47.88 -47.88 -47.88 -47.88 -47.88
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT 178.3 -52.8 -87.5 -100.3 -164.0 -.5 -.3 -.2 -.1 -.1
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF 133.3 3.8 -84.3 -100.0 -161.3 -13.2 -.4 -.3 -.2 -.1
WACC, % 11.1 11.1 11.1 11.1 11.1 11.1 11.1 11.1 11.1 11.1
PV UFCF
SUM PV UFCF -12.6
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value -1
Present Terminal Value -1
Enterprise Value -13
Net Debt 84
Equity Value -97
Diluted Shares Outstanding, MM 221
Equity Value Per Share -0.44

What You Will Get

  • Real Lexicon Data: Preloaded financials – from revenue to EBIT – based on actual and projected figures for Lexicon Pharmaceuticals, Inc. (LXRX).
  • Full Customization: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates to fit your analysis.
  • Instant Valuation Updates: Automatic recalculations to analyze the impact of changes on Lexicon's fair value.
  • Versatile Excel Template: Designed for quick edits, scenario testing, and detailed projections specific to Lexicon Pharmaceuticals, Inc. (LXRX).
  • Time-Saving and Accurate: Avoid building models from scratch while ensuring precision and flexibility in your financial analysis.

Key Features

  • 🔍 Real-Life LXRX Financials: Pre-filled historical and projected data for Lexicon Pharmaceuticals, Inc.
  • ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
  • 📊 Professional DCF Valuation: Built-in formulas calculate Lexicon’s intrinsic value using the Discounted Cash Flow method.
  • ⚡ Instant Results: Visualize Lexicon’s valuation instantly after making changes.
  • Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.

How It Works

  1. Download the Template: Gain immediate access to the Excel-based LXRX DCF Calculator.
  2. Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and other variables.
  3. Instant Calculations: The model automatically recalculates Lexicon Pharmaceuticals' intrinsic value.
  4. Test Scenarios: Experiment with various assumptions to assess potential changes in valuation.
  5. Analyze and Decide: Leverage the results to inform your investment or financial strategy.

Why Choose This Calculator for Lexicon Pharmaceuticals, Inc. (LXRX)?

  • Accuracy: Utilizes real Lexicon financial data for precise calculations.
  • Flexibility: Allows users to easily adjust and test various inputs.
  • Time-Saving: Avoid the complexity of constructing a DCF model from the ground up.
  • Professional-Grade: Engineered with the expertise and usability expected by finance professionals.
  • User-Friendly: Intuitive design ensures accessibility for users without extensive financial modeling skills.

Who Should Use This Product?

  • Professional Investors: Develop comprehensive and accurate valuation models for analyzing investments in Lexicon Pharmaceuticals (LXRX).
  • Corporate Finance Teams: Evaluate valuation scenarios to inform strategic decision-making within the organization.
  • Consultants and Advisors: Deliver precise valuation insights to clients interested in Lexicon Pharmaceuticals (LXRX).
  • Students and Educators: Utilize real-world data to learn and teach financial modeling techniques related to the pharmaceutical industry.
  • Healthcare Analysts: Gain insights into how biotech firms like Lexicon Pharmaceuticals (LXRX) are valued in the market.

What the Template Contains

  • Pre-Filled DCF Model: Lexicon Pharmaceuticals’ (LXRX) financial data preloaded for immediate use.
  • WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
  • Financial Ratios: Evaluate Lexicon Pharmaceuticals’ profitability, leverage, and efficiency.
  • Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
  • Financial Statements: Annual and quarterly reports to support detailed analysis.
  • Interactive Dashboard: Easily visualize key valuation metrics and results.

No products were found matching.